Serum leptin concentrations in patients with thyroid disorders

Tadashi Yoshida, Naoko Momotani, Matsuhiko Hayashi, Toshiaki Monkawa, Kunihiko Ito, Takao Saruta

研究成果: Article査読

60 被引用数 (Scopus)

抄録

OBJECTIVE. Leptin, the obese gene product, is secreted exclusively by adipocytes and is thought to act as a lipostatic signal that regulates body weight homeostasis. We previously reported that thyroid hormone is one of the up-regulating factors of leptin in vitro. T3, at physiological concentrations, stimulates leptin mRNA expression and leptin secretion by 3T3-L1 adipocytes. The aim of this study was to explore the role of thyroid hormone in the regulation of leptin in humans. DESIGN AND PATIENTS. A total of 59 non-obese women aged 38·4 + 1·8 years (mean · SEM) were studied: 19 patients with hyperthyroidism, 17 patients with hypothyroidism, and 23 normal control subjects. The correlation between serum leptin concentrations and body mass index (BMI) was analyzed, and serum leptin levels were compared among the three groups. MEASUREMENTS. Serum leptin concentrations were measured by radioimmunoassay. RESULTS. Serum leptin concentrations after logarithmic transformation were correlated significantly (P<0·05) with BMI in the hyperthyroid (r -0·46), the hypothyroid (r=0·84), and normal (r- 0·63) groups. Even though age, body weight, and BMI were similar in all groups, serum leptin levels in the hypothyroid patients (5·30 + 1·12 μg/l) were significantly (P<0·05) lower than in the hyperthyroid and normal groups (6·87 + 0·66 and 6·58 ± 0·68 μg/l, respectively). CONCLUSIONS. These results indicate that thyroid hormone may play an important role in the appropriate secretion of leptin in humans.

本文言語English
ページ(範囲)299-302
ページ数4
ジャーナルClinical Endocrinology
48
3
DOI
出版ステータスPublished - 1998

ASJC Scopus subject areas

  • 内分泌学、糖尿病および代謝内科学
  • 内分泌学

フィンガープリント

「Serum leptin concentrations in patients with thyroid disorders」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル